GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,674 | 3,845 | 4,452 | 4,981 | 4,687 |
| Receivables | 865 | 297 | 272 | 342 | 2,479 |
| Inventories | 650 | 289 | 297 | 299 | 246 |
| Income taxes - deferred | 14 | N/A | N/A | N/A | N/A |
| TOTAL | $5,441 | $4,550 | $5,177 | $5,724 | $7,540 |
| Non-Current Assets | |||||
| PPE Net | 243 | 68 | 57 | 59 | 61 |
| Intangibles | 2,122 | 995 | 970 | 1,043 | 875 |
| Other Non-Current Assets | 0 | 88 | 0 | 0 | 0 |
| TOTAL | $2,365 | $1,151 | $1,027 | $1,102 | $936 |
| Total Assets | $7,806 | $5,701 | $6,204 | $6,826 | $8,476 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 699 | 334 | 399 | 396 | 491 |
| Accrued Expenses | 468 | 205 | 326 | 393 | 829 |
| TOTAL | $4,227 | $539 | $725 | $949 | $2,680 |
| Non-Current Liabilities | |||||
| TOTAL | $41 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,268 | $539 | $725 | $949 | $2,680 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,538 | 42,538 | 42,368 | 41,908 | 41,308 |
| Common Shares | 43 | 42 | 42 | 42 | 41 |
| Retained earnings | -65,379 | -63,137 | -62,819 | -62,388 | -62,270 |
| Other shareholders' equity | 188 | 3,915 | 3,919 | 3,919 | -412 |
| TOTAL | $3,538 | $5,162 | $5,479 | $5,877 | $5,796 |
| Total Liabilities And Equity | $7,806 | $5,701 | $6,204 | $6,826 | $8,476 |